The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aerovate Therapeutics Inc | COM | 008064107 | 58,748 | 3,758,686 | SH | SOLE | 3,758,686 | 0 | 0 | ||
Akouos Inc | COM | 00973J101 | 7,106 | 1,515,074 | SH | SOLE | 1,515,074 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 46,464 | 499,824 | SH | SOLE | 499,824 | 0 | 0 | ||
Bolt Biotherapeutics Inc | COM | 097702104 | 5,619 | 2,754,437 | SH | SOLE | 2,754,437 | 0 | 0 | ||
Cincor Pharma Inc | COM | 17240Y109 | 105,013 | 5,573,949 | SH | SOLE | 5,573,949 | 0 | 0 | ||
Fusion Pharmaceuticals Inc | COM | 36118A100 | 194 | 78,066 | SH | SOLE | 78,066 | 0 | 0 | ||
Galera Therapeutics Inc | COM | 36338D108 | 4,009 | 3,083,712 | SH | SOLE | 3,083,712 | 0 | 0 | ||
Inozyme Pharm Inc | COM | 45790W108 | 17,436 | 3,655,308 | SH | SOLE | 3,655,308 | 0 | 0 | ||
Karuna Therapeutics Inc | COM | 48576A100 | 262,185 | 2,072,441 | SH | SOLE | 2,072,441 | 0 | 0 | ||
Natera Inc | COM | 632307104 | 109,884 | 3,100,560 | SH | SOLE | 3,100,560 | 0 | 0 | ||
Nextcure Inc | COM | 65343E108 | 12,558 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | ||
Nucana Biomed | Ordinary Shares | GB00BYWYV | 1,740 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
Nucana Biomed | SPONSORED ADR | 67022C106 | 4,060 | 5,599,999 | SH | SOLE | 5,599,999 | 0 | 0 | ||
ObsEva SA | COM | H5861P103 | 7,647 | 4,749,623 | SH | SOLE | 4,749,623 | 0 | 0 | ||
PDS Biotechnology Corporation | COM | 70465T107 | 521 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | ||
Synlogic Inc | COM | 87166L100 | 661 | 574,972 | SH | SOLE | 574,972 | 0 | 0 | ||
Vera Therapeutics Inc | CL A | 92337R101 | 43,299 | 3,181,442 | SH | SOLE | 3,181,442 | 0 | 0 | ||
Y-mAbs Therapeutics Inc | COM | 984241109 | 33,199 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 | ||
Adicet Bio Inc | COM | 007002108 | 7,568 | 518,379 | SH | SOLE | 518,379 | 0 | 0 | ||
Agenus Inc | COM | 00847G705 | 1,848 | 952,742 | SH | SOLE | 952,742 | 0 | 0 | ||
Amylyx Pharmaceuticals Inc | COM | 03237H101 | 3,609 | 187,381 | SH | SOLE | 187,381 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 5,683 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
AstraZeneca PLC | SPONSORED ADR | 046353108 | 20,902 | 316,360 | SH | SOLE | 316,360 | 0 | 0 | ||
Biomarin Pharmaceutical Inc | COM | 09061G101 | 24,994 | 301,605 | SH | SOLE | 301,605 | 0 | 0 | ||
Celldex Therapeutics Inc | COM | 15117B202 | 1,302 | 48,304 | SH | SOLE | 48,304 | 0 | 0 | ||
ChemoCentryx Inc | COM | 16383L106 | 6,195 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
ChemoCentryx Inc | COM | 16383L106 | 15,776 | 636,659 | SH | SOLE | 636,659 | 0 | 0 | ||
Chinook Therapeutics Inc | COM | 16961L106 | 4,838 | 276,609 | SH | SOLE | 276,609 | 0 | 0 | ||
CTI Biopharma Corp | COM | 12648L601 | 16,146 | 2,704,510 | SH | SOLE | 2,704,510 | 0 | 0 | ||
Cytokinetics Inc | COM | 23282W605 | 12,603 | 320,780 | SH | SOLE | 320,780 | 0 | 0 | ||
Dexcom Inc | COM | 252131107 | 14,093 | 189,092 | SH | SOLE | 189,092 | 0 | 0 | ||
Geron Corp | COM | 374163103 | 4,327 | 2,791,630 | SH | SOLE | 2,791,630 | 0 | 0 | ||
Geron Corp | COM | 374163103 | 1,550 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
Health Care Select Sector SPDR Fund | SIB HEALTHCARE | 81369Y209 | 38,472 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | |
Horizon Therapeutics PLC | SHS | G46188101 | 8,000 | 100,297 | SH | SOLE | 100,297 | 0 | 0 | ||
Immatics NV | SHS | N44445109 | 11,272 | 1,294,103 | SH | SOLE | 1,294,103 | 0 | 0 | ||
ImmunoGen Inc | COM | 45253H101 | 5,134 | 1,140,788 | SH | SOLE | 1,140,788 | 0 | 0 | ||
Inhibrx Inc | COM | 45720L107 | 1,679 | 147,935 | SH | SOLE | 147,935 | 0 | 0 | ||
Insmed Inc | COM PAR $.01 | 457669307 | 145 | 7,370 | SH | SOLE | 7,370 | 0 | 0 | ||
iRhythm Technologies Inc | COM | 450056106 | 15,350 | 142,091 | SH | SOLE | 142,091 | 0 | 0 | ||
Iveric Bio Inc | COM | 46583P102 | 6,282 | 653,047 | SH | SOLE | 653,047 | 0 | 0 | ||
Jounce Therapeutics Inc | COM | 481116101 | 2,975 | 981,928 | SH | SOLE | 981,928 | 0 | 0 | ||
Karuna Therapeutics Inc | COM | 48576A100 | 86 | 683 | SH | SOLE | 683 | 0 | 0 | ||
Merck & Co Inc | COM | 58933Y105 | 32,909 | 360,961 | SH | SOLE | 360,961 | 0 | 0 | ||
Natera Inc | COM | 632307104 | 85 | 2,400 | SH | SOLE | 2,400 | 0 | 0 | ||
Novo-Nordisk A S | ADR | 670100205 | 30,518 | 273,873 | SH | SOLE | 273,873 | 0 | 0 | ||
Prometheus Biosciences Inc | COM | 74349U108 | 10,908 | 386,395 | SH | SOLE | 386,395 | 0 | 0 | ||
Protagonist Therapeutics Inc | COM | 74366E102 | 791 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
Reata Pharmaceuticals Inc | CL A | 75615P103 | 23,821 | 783,851 | SH | SOLE | 783,851 | 0 | 0 | ||
Regenxbio Inc | COM | 75901B107 | 19,183 | 776,624 | SH | SOLE | 776,624 | 0 | 0 | ||
Sanofi SA | SPONSORED ADR | 80105N105 | 14,118 | 282,200 | SH | SOLE | 282,200 | 0 | 0 | ||
Sarepta Therapeutics Inc | COM | 803607100 | 9,838 | 131,245 | SH | SOLE | 131,245 | 0 | 0 | ||
Seagen Inc | COM | 81181C104 | 4,936 | 27,894 | SH | SOLE | 27,894 | 0 | 0 | ||
SPDR S&P Biotech ETF | S&P BIOTECH | 78464A870 | 14,854 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
SPDR S&P Biotech ETF | S&P BIOTECH | 78464A870 | 14,854 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
Syndax Pharmaceuticals Inc | COM | 87164F105 | 7,954 | 413,428 | SH | SOLE | 413,428 | 0 | 0 | ||
Travere Therapeutics Inc | COM | 89422G107 | 5,151 | 212,593 | SH | SOLE | 212,593 | 0 | 0 | ||
United Therapeutics Corp | COM | 91307C102 | 25,067 | 106,379 | SH | SOLE | 106,379 | 0 | 0 | ||
Vertex Pharmaceuticals Inc | COM | 92532F100 | 21,066 | 74,758 | SH | SOLE | 74,758 | 0 | 0 | ||
Xencor Inc | COM | 98401F105 | 4,329 | 158,164 | SH | SOLE | 158,164 | 0 | 0 | ||
Zentalis Pharmaceuticals Inc | COM | 98943L107 | 9,228 | 328,397 | SH | SOLE | 328,397 | 0 | 0 |